close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait
Tags Europe: Top News And Analysis Business News Europe News
From CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
Tags Biotechnology Obesity Health care industry
From CNBC.com News
Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
Tags Novo Nordisk A/S Health care industry Congress
From CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
Tags Breaking news Business News Law and Regulation
From CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Pharmaceuticals Business Insurance industry
From CNBC.com News
Stocks making the biggest moves midday: Shutterstock, Newell Brands, Zillow and more
Tags US Bancorp Xpeng Inc JPMorgan Chase & Co
From CNBC.com News
European regulator to review weight-loss drugs following reports of suicidal thoughts
Tags Novo Nordisk A/S Pharmaceuticals Business News
From CNBC.com News
Moderna strikes deal to develop mRNA drugs in China
Tags Pfizer Inc Business News AstraZeneca PLC
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Tags Pharmaceuticals Business Weight management
From CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
Tags Pfizer Inc Business News Biotechnology
From CNBC.com News
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Tags Health & Science Science US: News
From CNBC.com News
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
Tags US: News Science Health & Science
From CNBC.com News
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Tags Biotechnology Size and weight discrimination Novo Nordisk A/S
From CNBC.com News
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
Tickers LAW LAWS
Tags Health & Science US: News Laws
From CNBC.com News
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
Tags Novo Nordisk A/S Health care industry Obesity
From CNBC.com News
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Tags Health care industry Novo Nordisk A/S Congress
From CNBC.com News
Novo Nordisk cuts some U.S. supply of Wegovy obesity drug as demand soars
Tags Biotechnology Novo Nordisk A/S Drugs
From CNBC.com News
Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow
Tags Biotechnology Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds
Tags Politics Health & Science World News
From CNBC.com News
Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices
Tags Eli Lilly and Co Pharmaceuticals Business
From CNBC.com News
Senate legislation would cap insulin at $35 per month for people with private insurance
Tags Sanofi SA Biotechnology Congress
From CNBC.com News
Stocks making the biggest moves midday: Apple, Tesla, Netflix, Bed Bath & Beyond & more
Tags Novo Nordisk A/S Stock markets stocks
From CNBC.com News
Stocks making the biggest premarket moves: Delta, First Solar, Steve Madden & more
Tags Breaking News: Markets stocks Merck & Co Inc
From CNBC.com News
Health misinformation is lowering U.S. life expectancy, FDA Commissioner Robert Califf says
Tags Emergent BioSolutions Inc US: News Health care industry
From CNBC.com News
People taking obesity drugs Ozempic and Wegovy gain weight once they stop medication
Tags Business News Breaking news Breaking News: Business
From CNBC.com News
Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo Nordisk
Tags Breaking news Breaking News: Business Health care industry
From CNBC.com News
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly
Tags Health care industry Novo Nordisk A/S Breaking News: Business
From CNBC.com News
Biden proposal to cap all insulin prices at $35 a month has little chance of passing Congress
Tags Epidemics Biotech and Pharmaceuticals U/S/ Economy
From CNBC.com News
Trending billionaire and celebrity GLP-1 weight loss drugs are about to enter more American homes
Tags Novo Nordisk A/S Health care industry Obesity
From CNBC.com News
Cramer's lighting round: Stay away from Blackline
Tags Novo Nordisk A/S Stock markets Bloom Energy Corp
From CNBC.com News
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.